Jeroen Buijs

ORCID iD
https://orcid.org/0000-0001-5816-9739
  • Country
  • Show details Hide details
Netherlands

Sources:
Jeroen Buijs (2017-01-24)

  • Keywords
  • Show details Hide details
Coagulation,

Sources:
Jeroen Buijs (2017-01-24)

Thrombin,

Sources:
Jeroen Buijs (2017-01-24)

Breast cancer,

Sources:
Jeroen Buijs (2017-01-24)

Pancreatic cancer,

Sources:
Jeroen Buijs (2017-01-24)

FXa,

Sources:
Jeroen Buijs (2017-01-24)

Anticoagulants

Sources:
Jeroen Buijs (2017-01-24)

  • Websites
  • Show details Hide details
Einthoven Laboratory

Sources:
Jeroen Buijs (2017-01-24)

Biography

During his Ph.D. (obtained in 2009) at the department of Endocrinology (Leiden University Medical Centre he studied the pathogenesis and treatment of skeletal metastases. As a postdoctoral fellow (2010-2011) at the Indiana University (USA), he received a prostate cancer training award from the prostate cancer research program to set up a multidisciplenary study for radiation of bone (metastases). Upon his return in the LUMC at the department of Urology, he received a Veni grant (2012-2015) from the Netherlands Organisation for Scientific Research (NWO) to study the interactions of cancer stem cell-targeted agents in breast and prostate cancer. Since 2016 he is recruited to the Einthoven laboratory to study the role of coagulant factors and anticoagulant therapy in cancer progression.
No publications added yet